Search results
Showing 8131 to 8145 of 9042 results
Optical Coherence Tomography to guide percutaneous coronary intervention
In development Reference number: GID-IPG10394 Expected publication date: TBC
In development Reference number: GID-TA11310 Expected publication date: TBC
Tolebrutinib for treating primary progressive multiple sclerosis [ID6574]
In development Reference number: GID-TA11762 Expected publication date: 28 July 2025
Pembrolizumab–vibostolimab for untreated metastatic non-small-cell lung cancer [ID6365]
Discontinued Reference number: GID-TA11442
In development Reference number: GID-TA11441 Expected publication date: TBC
Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer [TSID10701]
In development Reference number: GID-TA11157 Expected publication date: TBC
Discontinued Reference number: GID-IPG10417
In development Reference number: GID-QS10176 Expected publication date: TBC
Deucravacitinib for treating active psoriatic arthritis [ID6561]
In development Reference number: GID-TA11510 Expected publication date: TBC
L-Dex U400 for lymphoedema after breast cancer treatment (MIB111)
April 2026: This Medtech innovation briefing has been withdrawn because the L-Dex U400 device is no longer available in the UK.
In development Reference number: GID-TA10960 Expected publication date: TBC
In development Reference number: GID-TA11627 Expected publication date: TBC
Sacituzumab govitecan for treating unresectable metastatic urothelial cancer [ID6150]
Discontinued Reference number: GID-TA11009
In development Reference number: GID-TA11679 Expected publication date: TBC
Etripamil for treating paroxysmal supraventricular tachycardia [ID6581]
In development Reference number: GID-TA11750 Expected publication date: TBC